-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$26.5763.71% Upside
Recent Analyst Forecasts and Stock Ratings
ACADIA Pharmaceuticals Inc. Frequently Asked Questions
-
What analysts cover ACADIA Pharmaceuticals Inc.?
ACADIA Pharmaceuticals Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, H.C. Wainwright, Robert W. Baird, Mizuho Securities, UBS in the past 90 days.